Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Abstract Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcom...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2021-07-01
|
| Sraith: | BMC Pulmonary Medicine |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12890-021-01607-2 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|